LivaNova PLC
LivaNova PLC (LIVN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LIVN · as of Sep 30, 2025
Ownership Breakdown
279
Institutional Holders
▲ 20 vs Q2
$2.89B
Total Inst. Value
▲ $429.36M vs Q2
54.93M
Shares Outstanding
freeFloat 99.55%
55.20M
13F Shares Held
▲ 524,044 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LIVN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. electromedical & electrotherapeutic apparatus | 7.25M | 13.28% | 13.28% | $379.68B | Nov 12, 2025 | ▼ 56.8K |
PRIMECAP MANAGEMENT CO/CA/ electromedical & electrotherapeutic apparatus | 4.44M | 8.14% | 8.14% | $232.82B | Nov 12, 2025 | ▼ 196.5K |
MILLENNIUM MANAGEMENT LLC electromedical & electrotherapeutic apparatus | 2.97M | 5.44% | 5.44% | $155.56B | Nov 14, 2025 | ▲ 544.0K |
ARTISAN PARTNERS LIMITED PARTNERSHIP electromedical & electrotherapeutic apparatus | 2.43M | 4.45% | 4.45% | $127.13B | Nov 12, 2025 | ▲ 1.18M |
WELLINGTON MANAGEMENT GROUP LLP electromedical & electrotherapeutic apparatus | 2.35M | 4.30% | 4.30% | $122.86B | Nov 14, 2025 | ▲ 1.07M |
VANGUARD GROUP INC electromedical & electrotherapeutic apparatus | 2.30M | 4.21% | 4.21% | $120.33B | Nov 7, 2025 | ▼ 157.7K |
STATE STREET CORP electromedical & electrotherapeutic apparatus | 2.06M | 3.77% | 3.77% | $107.69B | Nov 14, 2025 | ▼ 25.7K |
DIMENSIONAL FUND ADVISORS LP electromedical & electrotherapeutic apparatus | 1.72M | 3.15% | 3.15% | $90.15B | Nov 12, 2025 | ▲ 106.9K |
AQR CAPITAL MANAGEMENT LLC electromedical & electrotherapeutic apparatus | 1.66M | 3.04% | 3.04% | $86.90B | Nov 14, 2025 | ▼ 390.8K |
GEODE CAPITAL MANAGEMENT, LLC electromedical & electrotherapeutic apparatus | 1.45M | 2.65% | 2.65% | $75.76B | Nov 12, 2025 | ▲ 16.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
25
Increased
+4.67M shares1
New Positions
first time holders24
Decreased
−2.93M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.75M
+4.67M / −2.93M
Net new holders
+2
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LIVN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bianchi Francesco director | May 26, 2026 | Sale | 1,800 | $75.75 | $136.3K | 7.2K | Form 4 ↗ |
Tezel Ahmet Chief Innovation Officer | Mar 30, 2026 | Award | 13,873 | — | — | 13.9K | Form 4 ↗ |
Tezel Ahmet Chief Innovation Officer | Mar 30, 2026 | Award | 4,624 | — | — | 4.6K | Form 4 ↗ |
Tezel Ahmet Chief Innovation Officer | Mar 30, 2026 | Tax Withhold | 1,186 | $61.27 | $72.7K | 4.2K | Form 4 ↗ |
Poletti Franco President, Cardiopulmonary | Mar 30, 2026 | Tax Withhold | 1,370 | $61.27 | $83.9K | 10.8K | Form 4 ↗ |
Shvartsburg Alex Chief Financial Officer | Mar 30, 2026 | Tax Withhold | 12,868 | $61.27 | $788.4K | 44.6K | Form 4 ↗ |
Shvartsburg Alex Chief Financial Officer | Mar 30, 2026 | Award | 16,321 | — | — | 16.3K | Form 4 ↗ |
Shvartsburg Alex Chief Financial Officer | Mar 30, 2026 | Award | 5,440 | — | — | 5.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
LivaNova PLC (LIVN) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.45%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of LivaNova PLC is BLACKROCK, INC., holding approximately 7.25 million shares — equal to 13.28% of outstanding shares — as of September 30, 2025.
A total of 279 institutional investors currently hold LIVN stock, with a combined institutional value of approximately $2.89 billion as of the most recent 13F filing period.
Frequently asked questions
LIVN ownershipLivaNova PLC (LIVN) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 13.28% stake. Company insiders hold 0.45%. Data sourced from SEC Form 13F as of September 30, 2025.